MARIBAVIR Pharmacologic Class Indexing
- Class set ID
- b5a2190d-224b-4e79-bf08-6cc580c306ea
- Version
- 1
- Effective date
- 20220322
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use LIVTENCITY safely and effectively. See full prescribing information for LIVTENCITY. LIVTENCITY ® (maribavir) tablets, for oral use Initial U.S. Approval: 2021 | Takeda Pharmaceuticals America, Inc. | Catalent CTS, LLC | CARBOGEN AMCIS AG | JETPHARMA SA | Solvias AG | Privates Untersuchungsinstitut Heppeler GmbH | Takeda Ireland Limited | Almac Sciences (Ireland) Limited | Ajinomoto Omnichem | Eurofins Pharmaceutical Product Testing Belgium | 20260127 | 14 |